MANHARD KIMBERLY Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$4.09M

Insider Activity of MANHARD KIMBERLY

According to the SEC Form 4 filings, MANHARD KIMBERLY, being in a position of

  1. director at Inhibrx Biosciences Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2500 shares for $279,010,
    over all time since 2026-09-08, has bought 0 shares, and sold 2500 shares for $279,010.

Biography of MANHARD KIMBERLY

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $279,0105100

Comparison of Insiders on Amount of Buys and Sells

2026-09-15SaleInhibrx Biosciences Inc.
INBX
director
500
0.0034%
$105.05$52,525-10.04%
2026-09-14SaleInhibrx Biosciences Inc.
INBX
director
500
0.0032%
$110.26$55,130-13.86%
2026-09-11SaleInhibrx Biosciences Inc.
INBX
director
500
0.0033%
$111.78$55,888-12.78%
2026-09-09SaleInhibrx Biosciences Inc.
INBX
director
500
0.0035%
$115.80$57,898-15.24%
2026-09-08SaleInhibrx Biosciences Inc.
INBX
director
500
0.0032%
$115.14$57,570-15.76%
2022-05-03SaleHeron Therapeutics, Inc.
HRTX
EVP, Drug Development
1,504
0.0015%
$4.76$7,154-38.95%
2021-05-03SaleHeron Therapeutics, Inc.
HRTX
EVP, Drug Development
3,058
0.0032%
$17.66$54,017-39.34%
2020-12-22SaleHeron Therapeutics, Inc.
HRTX
EVP, Drug Development
20,000
0.0176%
$16.50$330,000-32.95%
2020-05-01SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
2,316
0.0013%
$6.98$16,176+25.16%
2019-11-29SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
48,000
0.0274%
$13.00$624,000-35.68%
2019-05-01SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
2,218
0.003%
$18.86$41,836+3.61%
2018-11-02SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
988
0.0014%
$30.62$30,250-30.06%
2018-10-01SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
12,000
0.0119%
$22.54$270,433-23.68%
2018-07-02SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
12,000
0.015%
$37.53$450,357-30.39%
2018-03-19SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
36,000
0.0438%
$21.50$774,000+9.71%
2018-01-10SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
15,168
0.019%
$16.50$250,272+47.17%
2017-04-24SaleHeron Therapeutics, Inc.
HRTX
Executive VP, Drug Development
43,084
0.0803%
$15.33$660,525+6.54%
2015-06-02SaleHeron Therapeutics, Inc.
HRTX
director
21,000
0.0688%
$23.58$495,180+12.42%
2015-06-01SaleHeron Therapeutics, Inc.
HRTX
director
5,416
0.0108%
$15.11$81,836+6.98%
Total: 19
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.